科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNS 科恩-斯蒂尔斯金融

盘前交易 07-24 09:14:27 EDT

79.98

-0.44

-0.55%

最高81.08	最低78.87	成交量31.68万
今开79.69	昨收80.42	日振幅2.74%
总市值41.10亿	流通市值22.06亿	总股本5,139万
成交额2,541万	换手率1.15%	流通股本2,758万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNS","market":"US","secType":"STK","nameCN":"科恩-斯蒂尔斯金融","latestPrice":79.98,"timestamp":1784836800000,"preClose":80.42,"halted":0,"volume":316783,"delay":0,"changeRate":-0.005471275802039265,"floatShares":27582175,"shares":51390184,"eps":3.250358,"marketStatus":"盘前交易","change":-0.44,"latestTime":"07-24 09:14:27 EDT","open":79.69,"high":81.075,"low":78.871,"amount":25409265.800559998,"amplitude":0.027406,"askPrice":85,"askSize":10,"bidPrice":79.59,"bidSize":43,"shortable":3,"etf":0,"ttmEps":3.250358,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784899800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1092369600000,"exchange":"NYSE","adjPreClose":79.98,"dividendRate":0.032258,"postHourTrading":{"tag":"盘后","latestPrice":79.98,"preClose":79.98,"latestTime":"19:34 EDT","volume":4827,"amount":386037.86,"timestamp":1784849652166,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8539384903935996,"impliedVol":0.2672,"impliedVolPercentile":0.424},"requestUrl":"/m/hq/s/CNS","defaultTab":"news","newsList":[{"id":"1173314657","title":"戴纳基宣布完成扩大公开发行及承销商全额行使超额配股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1173314657","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173314657?lang=zh_cn&edition=full","pubTime":"2026-07-24 04:11","pubTimestamp":1784837519,"startTime":"0","endTime":"0","summary":"马萨诸塞州沃尔瑟姆，2026年7月23日——戴纳基，一家专注于为遗传性神经肌肉疾病患者改善功能的临床阶段公司，今日宣布其此前公布的扩大承销公开发行已圆满结束。此次发行共计21,045,000股普通股，公开发行价为每股20.50美元，其中包含承销商全额行使选择权后额外购入的2,745,000股。戴纳基从此次发行中获得的总收益约为4.314亿美元，该数字已扣除承销折扣、佣金以及公司需支付的发行费用。发行中的所有股份均由戴纳基出售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","IE00BZ1G4Q59.USD","DYN","LU0557290698.USD","LU1791710582.SGD","LU2357305700.SGD","KBWB","LU0158827948.USD","LU0053666078.USD","BK4585","BK4516","BK4139","LU1244550494.USD","LU0098860793.USD","CNS","LU2023251221.USD","LU0106831901.USD","LU1244550577.SGD","LU2487616109.SGD","LU1720051108.HKD","LU2133065610.SGD","LU0795875169.SGD","LU0106261372.USD","BK4135","LU1668664300.SGD","LU1791710400.SGD","LU0225283273.USD","LU1989772923.USD","LU0006306889.USD","LU0210528500.USD","LU1162221912.USD","LU2089283258.USD","LU2271345857.HKD","BK4588","BK4504","BK4581","LU2111349929.HKD","LU1363072403.SGD","LU1074936037.SGD","BK4127","LU2028103732.USD","LU2089284900.SGD","IE00BKVL7J92.USD","LU1244550221.USD","IAI","BK4505","LU0795875086.SGD","LU0912757837.SGD","LU1732800096.USD","LU2347655156.SGD","LU0882574139.USD","LU1720051017.SGD","LU0390134368.USD","LU0528227936.USD","MS","LU0971096721.USD","LU1548497426.USD","LU0267386448.USD","LU1989772840.SGD","LU1064131342.USD","LU2264538146.SGD","BK4534","LU1732799900.SGD","LU0314104364.USD","LU1988902786.USD","LU0234570918.USD","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123630602","title":"科恩-斯蒂尔斯金融旗下优质收益房地产基金公布可转让优先认购权初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1123630602","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123630602?lang=zh_cn&edition=full","pubTime":"2026-07-16 21:01","pubTimestamp":1784206919,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融旗下优质收益房地产基金今日公布了其近期进行的可转让优先认购权的初步结果。本次行动旨在为基金注入新的资本，并进一步优化其投资组合结构。初步数据显示，市场对此次认购权发行反应积极，具体细节与最终分配方案将于后续完整报告中披露。基金管理团队表示，此举将增强基金在房地产领域的投资能力，并为股东创造长期价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RQI","CNS","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113557833","title":"财报前瞻 ｜科恩-斯蒂尔斯金融本季度营收预计增7.08%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1113557833","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113557833?lang=zh_cn&edition=full","pubTime":"2026-07-09 23:58","pubTimestamp":1783612723,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融将于2026年07月16日发布财报，市场普遍预期本季度营收和每股收益同比同步增长，关注管理费动能与费用率变化对利润弹性影响。上季度科恩-斯蒂尔斯金融实现营收1.46亿美元，同比增长8.31%；毛利率49.16%；归属于母公司股东的净利润为4,236.80万美元，净利率29.09%；调整后每股收益0.79美元，同比增长5.33%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜科恩-斯蒂尔斯金融本季度营收预计增7.08%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140110530","title":"科恩-斯蒂尔斯金融：迈克尔·多诺霍将留任临时首席财务官至2026年6月8日，之后继续担任财务总监","url":"https://stock-news.laohu8.com/highlight/detail?id=1140110530","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140110530?lang=zh_cn&edition=full","pubTime":"2026-05-22 04:31","pubTimestamp":1779395476,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融宣布，迈克尔·多诺霍将继续担任公司临时首席财务官一职，任期至2026年6月8日。在此日期之后，他将卸任临时首席财务官职务，并继续留任公司财务总监。\n这一安排确保了公司财务领导职务在过渡期间的稳定性。多诺霍在临时首席财务官任期结束后回归财务总监岗位，有助于维持公司财务职能的连续性与专业深度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102331783","title":"科恩-斯蒂尔斯与摩根大通达成战略合作，携手拓宽短期混合信贷SICAV策略的覆盖范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1102331783","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102331783?lang=zh_cn&edition=full","pubTime":"2026-05-21 09:00","pubTimestamp":1779325221,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融近日宣布，已与摩根大通建立了一项战略合作伙伴关系。此举旨在显著扩大其“短期混合信贷”SICAV投资策略的市场可及性。通过本次合作，双方将整合各自的专业优势与分销网络，为更广泛的投资者群体提供这一专注于短期、混合信贷资产的解决方案。\n该策略设计旨在寻求在可控的风险水平下，获取具有吸引力的收益。与摩根大通的联手，预计将借助后者强大的全球平台与客户基础，有效提升该策略产品的分销效率与市场渗透力。这一合作标志着科恩-斯蒂尔斯在拓展其专业投资策略全球影响力方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU2357627491.SGD","IE00BDRTCR15.USD","LU0882574139.USD","LU0203347892.USD","LU1974910355.USD","LU2023250843.SGD","LU1162221912.USD","LU1363072403.SGD","LU2746668461.USD","LU2237443895.HKD","LU0820562030.AUD","IE00BJTD4V19.USD","LU2462157665.USD","LU1116320901.HKD","LU1261432733.SGD","LU0267386448.USD","LU0211326755.USD","BK4581","LU0496365809.HKD","LU1116320737.USD","IE0034235295.USD","LU2237443978.SGD","IE00BKDWB100.SGD","LU0859254822.USD","IE00B1BXHZ80.USD","IE00BHPRN162.USD","LU1496350171.SGD","LU2237443465.HKD","LU0251132253.USD","LU2505996681.GBP","LU2054465674.USD","LU2242649171.HKD","JPX","LU2417539215.USD","JPO","LU0417517546.SGD","LU2211815571.USD","LU0211331839.USD","LU1551013425.SGD","LU1244550221.USD","LU1084165304.USD","LU0683600562.USD","LU0208291251.USD","LU1894683264.USD","LU2237443549.SGD","BK4504","BK4516","LU0345770993.USD","LU0070302665.USD","IE00BLSP4452.SGD","LU1244550577.SGD","LU1267930490.SGD","LU0211326839.USD","LU1629891620.HKD","LU2237443382.USD","LU2746668974.SGD","LU2756315664.SGD","LU0345770308.USD","LU1720051108.HKD","LU2552382132.HKD","BK4533","LU0215105999.USD","LU0265550946.USD","BK4207","BK4585","CNS","IE00BWXC8680.SGD","LU1551013342.USD","LU1720051017.SGD","LU2213496289.HKD","LU2756315318.SGD","IE00B3S45H60.SGD","LU1914381329.SGD","LU2505996509.AUD","LU2023250504.SGD","JPMO","LU2236285917.USD","LU0320765489.SGD","IE00BN8TJ469.HKD","LU0942090050.USD","LU2592432038.USD","LU1988902786.USD","LU0256863811.USD","BK4550","BK4135","LU2023250330.USD","LU0234572021.USD","LU0943347566.SGD","LU2106854487.HKD","LU0976567544.SGD","LU1366192091.USD","LU0106831901.USD","LU2552382215.SGD","LU1894683348.USD","LU0265550359.USD","LU2552382058.USD","LU1119994496.HKD","LU1548497426.USD","IE000M9KFDE8.USD","LU0971096721.USD","LU2264538146.SGD","LU0964807845.USD","LU0048584097.USD","LU1917777945.USD","IE0034235303.USD","IE00BFXG1179.USD","LU1280957306.USD","IE00BDCRKT87.USD","IE00B775SV38.USD","IE00BLSP4239.USD","LU1668664300.SGD","LU0203345920.USD","IE00BYXW3230.USD","LU0868494617.USD","LU0868494708.USD","LU2357305700.SGD","LU0238689110.USD","LU0345769631.USD","IE00BBT3K403.USD","LU0149725797.USD","BK4566","LU1145028129.USD","LU0640476718.USD","LU0689472784.USD","LU1496350502.SGD","LU0787776722.HKD","LU0820561909.HKD","IE00BKVL7J92.USD","LU2430703251.USD","IE0034235188.USD","LU1670628061.USD","LU2381873111.SGD","LU0820561818.USD","IE00BJLML261.HKD","LU2430703095.HKD","LU0211327993.USD","LU1064131342.USD","LU0310799852.SGD","LU0256863902.USD","LU1032466523.USD","LU0170899867.USD","LU0323591593.USD","BK4588","LU2456880835.USD","BK4534","LU0106261372.USD","LU0320765646.SGD","LU1670627923.USD","LU2430703178.SGD","IE00BJTD4N35.SGD","LU0006306889.USD","LU1244550494.USD","SG9999002224.SGD","LU0211328371.USD","LU0345769128.USD","IE00BZ1G4Q59.USD","IE00B1XK9C88.USD","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630356204","title":"都说CNS是个坑，艾伯维偏偏不信邪","url":"https://stock-news.laohu8.com/highlight/detail?id=2630356204","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630356204?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:32","pubTimestamp":1777260779,"startTime":"0","endTime":"0","summary":"然而，艾伯维却是一个例外。凭借CNS领域的强劲表现，艾伯维在2024年成功扭转下滑态势：营收同比增长4%，达到563.34亿美元；2025年更是迎来加速增长，同比增幅达8.6%，营收突破611.6亿美元。CNS业务的重要性，也在这一涨一跌中凸显无遗。02 艾伯维的CNS弹药箱艾伯维CNS的根基，在于2019年的那次关键收购。而Ubrelvy作为全球首款口服CGRP受体拮抗剂，主打急性偏头痛治疗；Qulipta则专注于成人发作性偏头痛和慢性偏头痛的预防，二者形成互补。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1777002450558131291","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["CNS","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127258539","title":"财报前瞻｜科恩-斯蒂尔斯金融本季度营收预计小幅提升，机构观点偏稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=1127258539","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127258539?lang=zh_cn&edition=full","pubTime":"2026-04-10 08:20","pubTimestamp":1775780457,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融将于2026年04月17日发布新一季度财报，市场聚焦费用率与利润弹性变化对盈利质量的影响。市场一致预期显示，本季度科恩-斯蒂尔斯金融营收预计为1.43亿美元，同比增长9.74%；调整后每股收益预计为0.81美元，同比增长6.58%。由于外部披露中未提供本季度毛利率与净利润或净利率的预测值，上述两项暂不展示。近期围绕科恩-斯蒂尔斯金融的新季度财报，主流机构观点更偏向稳健。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜科恩-斯蒂尔斯金融本季度营收预计小幅提升，机构观点偏稳健","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623930549","title":"上市后首份年报出炉，英硅智能如何以BD走稳商业化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623930549","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623930549?lang=zh_cn&edition=full","pubTime":"2026-03-31 14:49","pubTimestamp":1774939740,"startTime":"0","endTime":"0","summary":"3月29日，英硅智能公布了港股上市后的首份年报。紧随其后，英硅智能宣布与礼来达成27.5亿美元合作。根据协议，礼来将获得一项全球独家许可，用于开发、生产和商业化针对特定适应症、目前处于临床前开发阶段的、具有潜在“同类最佳”水平的新型口服治疗药物。此外，英硅智能与礼来还将围绕礼来选定的靶点开展多项研发项目合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690313762.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690313762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","BK1574","AIYY","BK4135","BK4585","CNS","BK4023","BK4587","AI","BK1191","AIPO","AGIX","CHAT","BK4528","VGT","01477","BK4551","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622568885","title":"英硅智能(03696)与元羿生物拓展AI驱动CNS领域研发合作 新合作总金额最高可达9475万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622568885","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622568885?lang=zh_cn&edition=full","pubTime":"2026-03-26 08:03","pubTimestamp":1774483392,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能 发布公告，在过去一年良好的合作关系基础上，英硅智能与Tenacia Biotechnology  Co., Limited，一家致力于为未被满足的神经系统疾病患者开发创新治疗方案的商业化生物制药公司，已达成一项扩展的AI驱动研发合作。本次拓展合作的总交易金额最高可达9475万美元。英硅智能有望获得元羿生物支付近期款项及里程碑款项等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","BK1141","AIPO","CNS","AGIX","BK4135","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153315660","title":"Reviva制药拟启动公开发行，募资推进精神分裂症三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1153315660","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153315660?lang=zh_cn&edition=full","pubTime":"2026-03-19 04:13","pubTimestamp":1773864804,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc.于2026年3月18日宣布，计划进行公开发行，出售其普通股及认股权证。本次发行全部由公司自身售股，最终完成将取决于市场及其他条件，发行规模与具体条款尚存不确定性。A.G.P./Alliance Global Partners担任此次发行的独家配售代理。公司计划将本次发行净收益连同现有现金及等价物，用于资助研发活动，其中包括brilaroxazine治疗精神分裂症的RECOVER-2三期临床试验，以及营运资本和其他一般企业用途。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","CNS","BK4007","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614031743","title":"Silo Pharma, Inc.盘中异动 早盘急速下跌9.66%报0.315美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614031743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614031743?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:31","pubTimestamp":1772029862,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时31分，Silo Pharma, Inc.股票出现波动，股价急速下挫9.66%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223102a4c7a676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223102a4c7a676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","SILO","BK4139","BK4135","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609432256","title":"释放pipeline in a drug潜力 NLRP3能否催生下一个“药王”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609432256","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609432256?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:35","pubTimestamp":1770280559,"startTime":"0","endTime":"0","summary":"近期，英硅智能(03696)宣布提名靶向NLRP3的外周限制性抑制剂ISM5059，该候选药物具有新颖母核，由英硅智能自有Pharma.AI平台驱动设计。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IBD","LU1169589451.USD","LU1169590202.USD","BK4132","BK4023","PD","CNS","AD","BBB","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517118521","title":"科恩-斯蒂尔斯金融盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517118521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517118521?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:51","pubTimestamp":1741294269,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时51分，科恩-斯蒂尔斯金融股票出现波动，股价快速拉升5.04%。科恩-斯蒂尔斯金融股票所在的资产管理行业中，整体跌幅为1.87%。科恩-斯蒂尔斯金融公司简介：科恩-斯蒂尔斯金融有限公司是一家专注于房地产证券的利基资产管理公司。科恩-斯蒂尔斯金融有限公司还管理专门的投资组合 优先证券、公用事业股票和其他高收益产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045109abebd343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045109abebd343&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4135"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516580686","title":"Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580686?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:52","pubTimestamp":1741017146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时52分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。截至发稿，该股报1.28美元/股，成交量2.1069万股，换手率0.47%，振幅4.43%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","SILO","CNS","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514438101","title":"Silo Pharma, Inc.盘中异动 股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514438101?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:44","pubTimestamp":1740671073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时44分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.67%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNS","BK4135","SILO","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086930","title":"Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514086930?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:30","pubTimestamp":1740594617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时30分，Silo Pharma, Inc.股票出现波动，股价急速拉升5.40%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SILO","CNS","BK4135","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514604186","title":"Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514604186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514604186?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:58","pubTimestamp":1740517098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时58分，Silo Pharma, Inc.股票出现异动，股价急速拉升5.56%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4139","BK4135","BK4202","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727576","title":"Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727576?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:48","pubTimestamp":1740408534,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","BK4135","SILO","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513153612","title":"Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513153612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513153612?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:02","pubTimestamp":1740160928,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时02分，Silo Pharma, Inc.股票出现波动，股价急速跳水5.03%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","CNS","SILO","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512624464","title":"CNS：急性自发性脑出血中的淋巴功能障碍，新的生物标志物揭示潜在机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2512624464","media":"亿欧网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512624464?lang=zh_cn&edition=full","pubTime":"2025-02-20 11:53","pubTimestamp":1740023639,"startTime":"0","endTime":"0","summary":"研究通过使用沿血管周围空间弥散指数作为新的生物标志物，揭示了淋巴清除功能受损与出血性脑损伤、水肿及较差临床结果之间的关系。浙江大学闫申强团队的研究表明，sICH患者同侧的DTI-ALPS显著降低，而对侧无显著差异，这为理解sICH病理生理学提供了新视角，并可能为治疗提供潜在靶点。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ky.jrj.com.cn/2025/02/20115348274749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cohenandsteers.com","stockEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":0.0518},{"period":"3month","weight":0.1812},{"period":"6month","weight":0.2135},{"period":"1year","weight":0.0593},{"period":"ytd","weight":0.274}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.034},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1639},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cohen & Steers, Inc.于2004年3月17日组建为特拉华州的公司。该公司是一家专注于实物资产和另类收入的全球投资管理公司，专注于上市和私人房地产、优先证券、基础设施、资源股票和大宗商品。该公司总部位于纽约市，通过在主要金融中心的办事处为全球机构和个人投资者提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.017702},{"month":2,"riseRate":0.5,"avgChangeRate":-0.001473},{"month":3,"riseRate":0.681818,"avgChangeRate":0.022621},{"month":4,"riseRate":0.681818,"avgChangeRate":0.055792},{"month":5,"riseRate":0.409091,"avgChangeRate":-0.003297},{"month":6,"riseRate":0.590909,"avgChangeRate":0.00096},{"month":7,"riseRate":0.636364,"avgChangeRate":0.030838},{"month":8,"riseRate":0.52381,"avgChangeRate":0.008352},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.011439},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.004744},{"month":11,"riseRate":0.636364,"avgChangeRate":0.008954},{"month":12,"riseRate":0.5,"avgChangeRate":0.016009}],"exchange":"NYSE","name":"科恩-斯蒂尔斯金融","nameEN":"Cohen & Steers"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科恩-斯蒂尔斯金融(CNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科恩-斯蒂尔斯金融,CNS,科恩-斯蒂尔斯金融股票,科恩-斯蒂尔斯金融股票老虎,科恩-斯蒂尔斯金融股票老虎国际,科恩-斯蒂尔斯金融行情,科恩-斯蒂尔斯金融股票行情,科恩-斯蒂尔斯金融股价,科恩-斯蒂尔斯金融股市,科恩-斯蒂尔斯金融股票价格,科恩-斯蒂尔斯金融股票交易,科恩-斯蒂尔斯金融股票购买,科恩-斯蒂尔斯金融股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科恩-斯蒂尔斯金融(CNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}